Figure 2 In the only case that has been subjected to a full postmortem examination our findings indicate that a subdural collection of intravenous feeding fluid may occur in the absence of venous thrombosis or apparent anatomical abnormality. This being the case, we would agree with suggestions that retrograde flow of parenteral nutrition infusion along the internal jugular vein to the transverse sinus, sagittal sinus and, via a ruptured bridging vein into the subdural space, is the likely mechanism. Together with bronchopulmonary dysplasia, raised pulmonary vascular resistance might have been the cause of increased venous pressure giving rise to retrograde flow.
Subdural accumulation of intravenous feeding fluid appears to be a very rare complication of parenteral nutrition given via a misplaced central venous catheter. It would seem prudent whenever possible to site the tip of the catheter within the mid right atrium in an attempt to minimise the risk of venous thrombosis or retrograde flow. Acute onset of neurological symptoms in an infant with a central venous catheter should raise the possibility of a subdural effusion.
We would like to thank Dr S Variand for his help with the postmortem examination of this case.
Abstract
Nebuliser drug delivery units were reused in 15% of paediatric wards participating in a national survey, while routine servicing and written information was provided by only half the wards issuing home nebulisers. Written information should be developed as a national resource, and further research on optimal cleaning practices is required.
Nebulisers are commonly used to treat children with severe asthma or cystic fibrosis in hospital and are increasingly prescribed for home treatment of very young children and those with chronic disease. While this may reduce the need for hospital admission, particularly of children with chronic conditions, it has been suggested that over-reliance on nebulised bronchodilators and inadequate supervision and education may increase the risk of life threatening asthmatic episodes.' Nebuliser drug delivery units are manufactured for use by a single patient only, and though reuse may save money, potential hazards include bacterial contamination2 and loss of efficiency of drug delivery. A recent King's Fund conference concluded that reuse of items manufactured for single patient use was undesirable and recommended development of guidelines governing reuse at district levels. 3 This survey aimed to determine current cleaning and reuse practices and to obtain information on the advice and support given to parents issued with a home nebuliser in a nationally representative sample of paediatric wards in England. We also sought to establish whether guidelines governing reuse were available at district health authority level.
